RNXT RenovoRx Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RNXT

Price (delayed)

$1.21

Market cap

$20.41M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.99

Enterprise value

$19.23M

Highlights
The EPS has grown by 9% YoY but it has contracted by 5% from the previous quarter
The company's equity has shrunk by 149% YoY
The quick ratio has plunged by 83% YoY and by 50% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of RNXT
Market
Shares outstanding
16.87M
Market cap
$20.41M
Enterprise value
$19.23M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$10.12M
EBITDA
-$10.12M
Free cash flow
-$10.26M
Per share
EPS
-$0.99
Free cash flow per share
-$1
Book value per share
-$0.28
Revenue per share
$0
TBVPS
$0.14
Balance sheet
Total assets
$1.47M
Total liabilities
$4.47M
Debt
$0
Equity
-$3M
Working capital
$291,000
Liquidity
Debt to equity
0
Current ratio
1.25
Quick ratio
1
Net debt/EBITDA
0.12
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-258.1%
Return on equity
-2,822.6%
Return on invested capital
N/A
Return on capital employed
-3,479%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RNXT stock price

How has the RenovoRx stock price performed over time
Intraday
-4.72%
1 week
-2.42%
1 month
-2.42%
1 year
-57.69%
YTD
-47.16%
QTD
-13.57%

Financial performance

How have RenovoRx's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.4M
Net income
-$10.23M
Gross margin
N/A
Net margin
N/A
The operating income is down by 15% YoY but it is up by 3.3% QoQ
The net income has declined by 12% since the previous quarter and by 3.5% year-on-year

Growth

What is RenovoRx's growth rate over time

Valuation

What is RenovoRx stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 9% YoY but it has contracted by 5% from the previous quarter
The company's equity has shrunk by 149% YoY

Efficiency

How efficient is RenovoRx business performance
RNXT's ROA has plunged by 172% YoY and by 53% from the previous quarter

Dividends

What is RNXT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RNXT.

Financial health

How did RenovoRx financials performed over time
RNXT's total assets is 67% smaller than its total liabilities
The quick ratio has plunged by 83% YoY and by 50% from the previous quarter
The current ratio has dropped by 81% year-on-year and by 43% since the previous quarter
RenovoRx's debt is 100% higher than its equity
The company's equity has shrunk by 149% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.